Insider trades
Danny L. Dearen, Director of Beta Bionics BBNX, has filed 0 purchases and 14 sales on the open market. The latest trade was on 05/21.
Danny L. Dearen
Director
- Company
- Beta Bionics BBNX
- First filing
- 23/02/02
- Trades
- 37 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- No record
- Last trade
- 05/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market saleAmendment | 22/02/03–23/09/29 | 23/10/03 | 26,359 sh3 trades | $50.76avg. | $1,338,009.43 | −52.6% | |
| Open-market sale10b5-1 plan | 23/05/26 | 23/05/31 | 7,999 sh2 trades | $49.47avg. | $395,680.56 | −46.5% | |
| Open-market sale10b5-1 plan | 23/04/21 | 23/04/25 | 20,000 sh2 trades | $60.20avg. | $1,204,093.09 | −53.8% | |
| Open-market sale10b5-1 plan | 23/04/20 | 23/04/24 | 2,001 sh | $60.01 | $120,080.01 | −7.7% | |
| Open-market sale10b5-1 plan | 23/03/31 | 23/04/04 | 15,000 sh2 trades | $55.27avg. | $829,081.7 | −38.5% | |
| Open-market sale | 23/01/31–23/02/01 | 23/02/02 | 13,757 sh4 trades | $61.10avg. | $840,613.13 | −36.4% |